Proteomics in acute myelogenous leukaemia (AML): methodological strategies and identification of protein targets for novel antileukaemic therapy.

Sjøholt, Gry; Anensen, Nina; Wergeland, Line; Mc Cormack, Emmet; Bruserud, Øystein; Gjertsen, Bjørn Tore

Sjøholt, Gry; Anensen, Nina; Wergeland, Line; Mc Cormack, Emmet; Bruserud, Øystein; Gjertsen, Bjørn Tore.

Affiliation

Sjøholt G; Institute of Medicine, Hematology Section, University of Bergen and Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway. Bjorn.Gjertsen@med.uib.no.

Curr Drug Targets ; 6(6): 631-46, 2005 Sep.

Article in En | MEDLINE | ID: mdl-16178797

Subject(s)

Leukemia, Myeloid, Acute/drug therapy; Leukemia, Myeloid, Acute/metabolism; Neoplasm Proteins/antagonists & inhibitors; Neoplasm Proteins/analysis; Proteomics; Acetylation; Apoptosis; Gene Expression Regulation; Hematopoiesis; Histones/metabolism; Humans; Mass Spectrometry; Protein Array Analysis; Signal Transduction; Tumor Suppressor Protein p53/physiology

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Proteomics / Neoplasm Proteins Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Curr Drug Targets Journal subject: TERAPIA POR MEDICAMENTOS Year: 2005 Type: Article Affiliation country: Norway

Search on Google

Add to My VHL

XML

PubMed Links